Journal articleCancer Chemother Pharmacol2013
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.
- Journal
- Cancer Chemother Pharmacol
- Published
- 5 February 2013
- Citations
- 235
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 4
- Its registry lists this paper as resultsA Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer NCT01049880↗
- BackgroundA Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients NCT03541486↗
- BackgroundGemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I NCT01852890↗
- BackgroundClinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer NCT01515046↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.